Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens

Supporting evidence

• Review decision

• Review decision – October 2019

• Review proposal paper (PDF 245 KB)

  Published:

  07 November 2019

• Stakeholder list (PDF 178 KB)

  Published:

  07 November 2019

• Evaluation report

• Committee papers (PDF 19.61 MB)

  Published:

  21 December 2016